vs
Side-by-side financial comparison of AVIAT NETWORKS, INC. (AVNW) and COLLEGIUM PHARMACEUTICAL, INC (COLL). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $111.5M, roughly 1.8× AVIAT NETWORKS, INC.). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs 5.1%, a 3.1% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs -5.7%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $22.5M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 0.3%).
Aviat Networks, Inc. is a global provider of microwave transport and backhaul solutions, providing public and private operators with communications infrastructure to serve telecommunications operators and enterprise customers.
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
AVNW vs COLL — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $111.5M | $205.4M |
| Net Profit | $5.7M | $17.0M |
| Gross Margin | 32.4% | 62.5% |
| Operating Margin | 6.5% | 29.6% |
| Net Margin | 5.1% | 8.3% |
| Revenue YoY | -5.7% | 12.9% |
| Net Profit YoY | 27.2% | 35.3% |
| EPS (diluted) | $0.44 | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $111.5M | $205.4M | ||
| Q3 25 | $107.3M | $209.4M | ||
| Q2 25 | $115.3M | $188.0M | ||
| Q1 25 | $112.6M | $177.8M | ||
| Q4 24 | $118.2M | $181.9M | ||
| Q3 24 | $88.4M | $159.3M | ||
| Q2 24 | $116.7M | $145.3M | ||
| Q1 24 | $110.8M | $144.9M |
| Q4 25 | $5.7M | $17.0M | ||
| Q3 25 | $162.0K | $31.5M | ||
| Q2 25 | $5.2M | $12.0M | ||
| Q1 25 | $3.5M | $2.4M | ||
| Q4 24 | $4.5M | $12.5M | ||
| Q3 24 | $-11.9M | $9.3M | ||
| Q2 24 | $1.5M | $19.6M | ||
| Q1 24 | $3.9M | $27.7M |
| Q4 25 | 32.4% | 62.5% | ||
| Q3 25 | 33.2% | 61.7% | ||
| Q2 25 | 34.2% | 57.7% | ||
| Q1 25 | 34.9% | 54.8% | ||
| Q4 24 | 34.6% | 54.0% | ||
| Q3 24 | 22.4% | 60.8% | ||
| Q2 24 | 35.3% | 62.5% | ||
| Q1 24 | 32.5% | 63.1% |
| Q4 25 | 6.5% | 29.6% | ||
| Q3 25 | 4.8% | 29.7% | ||
| Q2 25 | 7.7% | 18.7% | ||
| Q1 25 | 8.3% | 12.2% | ||
| Q4 24 | 6.7% | 20.9% | ||
| Q3 24 | -17.6% | 21.9% | ||
| Q2 24 | 4.7% | 32.7% | ||
| Q1 24 | 5.1% | 34.1% |
| Q4 25 | 5.1% | 8.3% | ||
| Q3 25 | 0.2% | 15.0% | ||
| Q2 25 | 4.5% | 6.4% | ||
| Q1 25 | 3.1% | 1.4% | ||
| Q4 24 | 3.8% | 6.9% | ||
| Q3 24 | -13.4% | 5.9% | ||
| Q2 24 | 1.3% | 13.5% | ||
| Q1 24 | 3.5% | 19.1% |
| Q4 25 | $0.44 | $0.48 | ||
| Q3 25 | $0.01 | $0.84 | ||
| Q2 25 | $0.42 | $0.34 | ||
| Q1 25 | $0.27 | $0.07 | ||
| Q4 24 | $0.35 | $0.36 | ||
| Q3 24 | $-0.94 | $0.27 | ||
| Q2 24 | $0.11 | $0.52 | ||
| Q1 24 | $0.30 | $0.71 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.5M | $386.7M |
| Total DebtLower is stronger | $105.4M | — |
| Stockholders' EquityBook value | $271.6M | $301.7M |
| Total Assets | $659.4M | $1.7B |
| Debt / EquityLower = less leverage | 0.39× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $86.5M | $386.7M | ||
| Q3 25 | $64.8M | $285.9M | ||
| Q2 25 | $59.7M | $222.2M | ||
| Q1 25 | $49.4M | $197.8M | ||
| Q4 24 | $52.6M | $162.8M | ||
| Q3 24 | $51.0M | $120.0M | ||
| Q2 24 | $64.6M | $271.6M | ||
| Q1 24 | $59.2M | $318.0M |
| Q4 25 | $105.4M | — | ||
| Q3 25 | $106.5M | — | ||
| Q2 25 | $87.6M | — | ||
| Q1 25 | $73.9M | — | ||
| Q4 24 | $74.9M | — | ||
| Q3 24 | $83.4M | — | ||
| Q2 24 | $48.4M | — | ||
| Q1 24 | $48.9M | — |
| Q4 25 | $271.6M | $301.7M | ||
| Q3 25 | $263.6M | $274.8M | ||
| Q2 25 | $263.2M | $232.2M | ||
| Q1 25 | $256.1M | $234.4M | ||
| Q4 24 | $249.6M | $228.8M | ||
| Q3 24 | $247.1M | $234.3M | ||
| Q2 24 | $255.9M | $216.6M | ||
| Q1 24 | $256.0M | $222.2M |
| Q4 25 | $659.4M | $1.7B | ||
| Q3 25 | $643.3M | $1.6B | ||
| Q2 25 | $633.3M | $1.6B | ||
| Q1 25 | $628.3M | $1.6B | ||
| Q4 24 | $594.1M | $1.7B | ||
| Q3 24 | $590.9M | $1.6B | ||
| Q2 24 | $535.2M | $1.1B | ||
| Q1 24 | $490.3M | $1.1B |
| Q4 25 | 0.39× | — | ||
| Q3 25 | 0.40× | — | ||
| Q2 25 | 0.33× | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | 0.30× | — | ||
| Q3 24 | 0.34× | — | ||
| Q2 24 | 0.19× | — | ||
| Q1 24 | 0.19× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $23.9M | $123.0M |
| Free Cash FlowOCF − Capex | $22.5M | $122.4M |
| FCF MarginFCF / Revenue | 20.2% | 59.6% |
| Capex IntensityCapex / Revenue | 1.3% | 0.3% |
| Cash ConversionOCF / Net Profit | 4.18× | 7.25× |
| TTM Free Cash FlowTrailing 4 quarters | $16.1M | $327.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $23.9M | $123.0M | ||
| Q3 25 | $-11.7M | $78.4M | ||
| Q2 25 | $10.5M | $72.4M | ||
| Q1 25 | $1.6M | $55.4M | ||
| Q4 24 | $20.8M | $84.6M | ||
| Q3 24 | $-27.2M | $-9.0M | ||
| Q2 24 | $8.3M | $67.4M | ||
| Q1 24 | $15.3M | $61.9M |
| Q4 25 | $22.5M | $122.4M | ||
| Q3 25 | $-13.5M | $78.3M | ||
| Q2 25 | $8.2M | $72.4M | ||
| Q1 25 | $-1.2M | $54.6M | ||
| Q4 24 | $18.3M | $84.1M | ||
| Q3 24 | $-32.6M | $-9.2M | ||
| Q2 24 | $7.5M | $67.1M | ||
| Q1 24 | $14.8M | $61.4M |
| Q4 25 | 20.2% | 59.6% | ||
| Q3 25 | -12.6% | 37.4% | ||
| Q2 25 | 7.1% | 38.5% | ||
| Q1 25 | -1.0% | 30.7% | ||
| Q4 24 | 15.5% | 46.2% | ||
| Q3 24 | -36.8% | -5.8% | ||
| Q2 24 | 6.4% | 46.2% | ||
| Q1 24 | 13.4% | 42.3% |
| Q4 25 | 1.3% | 0.3% | ||
| Q3 25 | 1.6% | 0.1% | ||
| Q2 25 | 2.0% | 0.0% | ||
| Q1 25 | 2.5% | 0.4% | ||
| Q4 24 | 2.1% | 0.3% | ||
| Q3 24 | 6.1% | 0.2% | ||
| Q2 24 | 0.7% | 0.2% | ||
| Q1 24 | 0.4% | 0.4% |
| Q4 25 | 4.18× | 7.25× | ||
| Q3 25 | -72.48× | 2.49× | ||
| Q2 25 | 2.02× | 6.05× | ||
| Q1 25 | 0.46× | 22.92× | ||
| Q4 24 | 4.62× | 6.75× | ||
| Q3 24 | — | -0.96× | ||
| Q2 24 | 5.37× | 3.44× | ||
| Q1 24 | 3.96× | 2.23× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNW
| Products | $81.2M | 73% |
| Services | $30.3M | 27% |
COLL
Segment breakdown not available.
